Fluorinated pyrimidines: a new change for old drugs
King, D.H.
Transplantation Proceedings 23(3 Suppl 3: 168-170
1991
ISSN/ISBN: 0041-1345 PMID: 1648825 Document Number: 370768
Document emailed within 1 workday
Related Documents
Furue, H. 1984: Fluorinated pyrimidines--administration methods Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(11): 2329-2334Oki, T.; Heidelberger, C. 1971: Fluorinated pyrimidines. 39. Effects of 5-trifluoromethyl-2'-deoxyuridine on the replication of vaccinia viral messenger ribonucleic acid and proteins Molecular Pharmacology 7(6): 653-662
Cieplik, J. 1992: Pyrimidines as the potential circulatory drugs Acta Poloniae Pharmaceutica 49(4): 67-71
El-Bahaie, S.; el-Deeb, A.; Assy, M.C. 1991: Synthesis and biological activity of some 4-substituted pyrimidines and fused pyrimidines Die Pharmazie 46(1): 26-28
Narayanan, A.; Pradet, A. 1974: Fluorinated quinazolones: effect of some fluorinated 2-alkyl-3-aryl-4(3H)-quinazolones and thioquinazolones on pyruvic acid oxidation in rat brain homogenates Indian Journal of Experimental Biology 12(3): 286-287
Zhang, X.P.; Zhang, X.J.; Zheng, X.H.; Chen, L.; Dai, Z.R. 1980: Studies on antimalarials. I. Synthesis and antimalarial activities of some derivatives of 2,4-diamino-5-substituted amino pyrimidines and 2,4-diamino-6-methyl-5-substituted amino pyrimidines Yao Xue Xue Bao 15(12): 711-718
Akimov, V.G.; Omel'chenko, O.G.; Lashmanova, A.P. 1985: Deliberate change of the rate of biotransformation of drugs Vestnik Dermatologii i Venerologii 7: 18-20
Seleznev, E.F.; Krikov, V.I. 1988: Change in the indices of hematological studies induced by drugs Laboratornoe Delo 1988(2): 68-77
Reinke, T. 2017: Regimen Change: Gilead's TAF Drugs Toppling TDFs in HIV Treatment Managed Care 26(9): 10-11
Yang, J.; Xie, R.; Krewski, D.; Wang, Y.; Walker, M.; Cao, W.; Wen, S.Wu. 2014: Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs Chinese Medical Journal 127(4): 702-706
Labeeuw, M.; Cabanne, J.F.; Dubot, P. 1987: Minimal change nephrotic syndrome associated with non steroidal antiinflammatory drugs. a need for careful evaluation Clinical Nephrology 27(3): 162
Bai, R.; Liu, N.; Hu, D.; Ma, C. 2014: Urgent action is needed to change the status of "orphan drugs" in cardiology in China Zhonghua Xin Xue Guan Bing Za Zhi 42(7): 543-544
Boelaert, M.; Le Ray, D.; Van Der Stuyft, P. 2002: How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis Tropical Medicine and International Health: Tm and Ih 7(11): 955-959
Gogus, F.Y.; Toker, K.; Baykan, N. 1991: Hepatitis following use of two different fluorinated anesthetic agents Israel Journal of Medical Sciences 27(3): 156-159
Lin, H.D.; Tai, F.T.; Chen, H.D.; Lee, S.P.; Chang, F.Y.; Wang, G.G.; Tang, K.T.; Lee, J.K. 1991: Change of circulating thyroid autoantibody titers in Graves' hyperthyroidism after antithyroid drugs therapy Zhonghua Yi Xue Za Zhi 47(2): 86-90
Giammanco, L.; Invidiata, F.P. 1986: Synthesis of 4(2H-1,2,3-triazol-2-yl)pyrimidines Il Farmaco; Edizione Scientifica 41(3): 225-228
Ramos, M.T.; Díaz-Guerra, L.M.; García-Copín, S.; Avendaño, C.; García-Grávalos, D.; García de Quesada, T. 1996: Synthesis and antitumour activity of fluorinated 1-aza and 1,8-diazaanthraquinones Farmaco 51(5): 375-379
Viñes, J.J. 1971: Prevention of dental caries using fluorinated salt Revista Clinica Espanola 120(4): 319-334
Pietrogrande, A.; Fini, G.D. 1976: Microdetermination of carbon-hydrogen in fluorinated perfluorinated compound Il Farmaco; Edizione Pratica 31(6): 332-338
Charlon, C.; Luu-Duc, C. 1986: Fluorinated phenylethylamines: synthesis and limitations of various fluorinating methods Annales Pharmaceutiques Francaises 44(2): 123-132